수의 건강용 모노클로널 항체 시장 보고서(2026년)

Monoclonal antibodies in veterinary health are engineered proteins designed to target and neutralize specific pathogens or toxins in animals, assisting in the diagnosis and treatment of various diseases. They are produced by cloning a single type of immune cell to generate identical antibodies that specifically bind to their target.

Monoclonal antibodies in veterinary health are primarily used for dogs, although they can also be used for other animals. Monoclonal antibodies are applied in fields such as dermatology and pain management, with end users including veterinary hospitals and other related facilities.

Tariffs have affected the monoclonal antibodies in veterinary health market by increasing the cost of imported biologics, laboratory equipment, and advanced reagents. Segments such as canine cancer treatments and autoimmune disorder therapies are most impacted, particularly in regions like North America and Europe that rely heavily on imports. While tariffs create cost pressures, they also encourage local production, innovation in cost-effective antibody therapies, and development of regionally optimized veterinary mAbs.

The monoclonal antibodies in veterinary health market research report is one of a series of new reports from The Business Research Company that provides monoclonal antibodies in veterinary health market statistics, including monoclonal antibodies in veterinary health industry global market size, regional shares, competitors with a monoclonal antibodies in veterinary health market share, detailed monoclonal antibodies in veterinary health market segments, market trends and opportunities, and any further data you may need to thrive in the monoclonal antibodies in veterinary health industry. This monoclonal antibodies in veterinary health market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The monoclonal antibodies in veterinary health market size has grown rapidly in recent years. It will grow from $0.92 billion in 2025 to $1.06 billion in 2026 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to rising prevalence of canine cancers, increasing incidence of autoimmune disorders in pets, limited availability of targeted therapies, growth of veterinary hospitals, awareness of advanced veterinary treatments.

The monoclonal antibodies in veterinary health market size is expected to see rapid growth in the next few years. It will grow to $1.85 billion in 2030 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to technological advancements in mAb engineering, increasing adoption of species-specific therapies, rising investment in veterinary oncology and dermatology, growth of personalized veterinary medicine, expansion of global veterinary healthcare infrastructure. Major trends in the forecast period include growth in monoclonal antibody-based canine cancer treatments, rising use of mabs for autoimmune disorders in dogs, expansion of veterinary dermatology applications, increasing adoption of targeted pain management therapies, development of species-specific antibody therapies for cats, horses, and livestock.

The rising incidence of animal diseases is expected to drive the growth of the monoclonal antibodies in veterinary health market going forward. The increase in animal disease incidence is driven by intensified farming practices, which elevate the risk of infectious disease spread, and climate change, which expands the range of disease vectors such as ticks and mosquitoes. Monoclonal antibodies are highly effective for treating animal diseases as they target specific pathogens or proteins involved in disease processes, offering precise and targeted treatments. For example, in June 2024, according to a report published by GOV.UK, a UK-based government website, between April 2023 and March 2024, the number of animals slaughtered due to TB incidents rose by 5% in England to 21,298 and by 17% in Wales to 11,197. Therefore, the rising incidence of animal diseases is driving the growth of the monoclonal antibodies in veterinary health market.

Leading players in the monoclonal antibodies in veterinary health market are focusing on developing innovative veterinary therapeutic solutions, such as anti-NGF monoclonal antibody treatments to address conditions like chronic pain and inflammation in animals. Anti-NGF monoclonal antibody treatment is a therapeutic approach that targets and inhibits nerve growth factor (NGF) to reduce pain and inflammation in animals suffering from chronic conditions. For instance, in May 2023, Zoetis, a US-based animal health company, received FDA approvals for Librela (bedinvetmab injection), the first monoclonal antibody treatment for controlling pain associated with osteoarthritis (OA) in dogs, administered as a once-monthly injection, and Apoquel Chewable, the first chewable medication for managing allergic itch and inflammation in dogs aged one year or older. Librela targets and inhibits NGF, blocking pain signals from reaching the brain and thereby reducing the sensation of pain in dogs with osteoarthritis. Librela represents a major advancement in veterinary pain management, providing a novel approach to treating chronic pain in dogs.

In January 2024, Ceva Sante Animale, a France-based provider of animal health products and services, acquired Scout Bio Inc. for an undisclosed amount. This acquisition allows Ceva Sante to strengthen its global biotechnology efforts in animal health by leveraging Scout Bio's expertise in advanced therapies such as gene therapy and monoclonal antibodies, accelerating innovation to address chronic diseases in pets. Scout Bio Inc. is a US-based biotechnology company developing a pipeline of monoclonal antibody therapies for chronic conditions in pets.

Major companies operating in the monoclonal antibodies in veterinary health market are Zoetis Inc, Boehringer Ingelheim International GmbH, MSD Animal Health, Elanco Animal Health Incorporated, Heska Corporation, Ceva Sante Animale S.A., Biogenesis Bago S.A., PetMedix Ltd, Merck & Co Inc, Virbac SA, Kindred Biosciences Inc, Dechra Pharmaceuticals, Vetigenics, Akston Biosciences Corporation, MabGenesis Inc, IDEXX Laboratories Inc, Nexvet Biopharma, Epitopix LLC, Indian Immunologicals Ltd, Vetoquinol, Phibro Animal Health, Norbrook Laboratories, AnimalCare, Eco Animal Health, Venkys, Hester Biosciences Limited, ImmuCell

North America was the largest region in the monoclonal antibodies in veterinary health market in 2025. The regions covered in the monoclonal antibodies in veterinary health market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the monoclonal antibodies in veterinary health market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The monoclonal antibodies in veterinary health market consist of sales of diagnostic kits, therapeutic drugs, research reagents, monoclonal antibody drugs, and therapeutic formulations. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Monoclonal Antibodies In Veterinary Health Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses monoclonal antibodies in veterinary health market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for monoclonal antibodies in veterinary health ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The monoclonal antibodies in veterinary health market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Monoclonal Antibodies (mAbs); Glucocorticoids; Antihistamines; Immunosuppressants; Other Products
• 2) By Animal Type: Dogs; Cats; Horses; Livestock; Other Animals
• 3) By Indication: Allergic Skin Disease; Autoimmune Disorders; Infectious Diseases; Cancer Or Tumor Therapy; Other Indications
• 4) By Route Of Administration: Injectable; Oral; Topical
• 5) By Distribution Channel: Veterinary Clinics; Specialized Animal Hospitals; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
• Subsegments:
• 1) By Monoclonal Antibodies: Lokivetmab; Felvetmab; Investigational Monoclonal Antibodies; Equine-specific mAbs
• 2) By Glucocorticoids: Prednisone; Prednisolone; Dexamethasone; Methylprednisolone; Hydrocortisone; Triamcinolone
• 3) By Antihistamines: Diphenhydramine; Hydroxyzine; Cetirizine; Loratadine; Chlorpheniramine
• 4) By Immunosuppressants: Cyclosporine; Tacrolimus; Azathioprine; Mycophenolate Mofetil
• 5) By Other Products: Essential Fatty Acid Supplements; Medicated Shampoos And Sprays; Allergen-Specific Immunotherapy (ASIT); Skin Barrier Repair Creams; Nutraceuticals And Probiotics
• Companies Mentioned: Zoetis Inc; Boehringer Ingelheim International GmbH; MSD Animal Health; Elanco Animal Health Incorporated; Heska Corporation; Ceva Sante Animale S.A.; Biogenesis Bago S.A.; PetMedix Ltd; Merck & Co Inc; Virbac SA; Kindred Biosciences Inc; Dechra Pharmaceuticals; Vetigenics; Akston Biosciences Corporation; MabGenesis Inc; IDEXX Laboratories Inc; Nexvet Biopharma; Epitopix LLC; Indian Immunologicals Ltd; Vetoquinol; Phibro Animal Health; Norbrook Laboratories; AnimalCare; Eco Animal Health; Venkys; Hester Biosciences Limited; ImmuCell
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Monoclonal Antibodies In Veterinary Health Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Monoclonal Antibodies In Veterinary Health Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Monoclonal Antibodies In Veterinary Health Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Monoclonal Antibodies In Veterinary Health Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Industry 4.0 & Intelligent Manufacturing
  • 4.1.2 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.3 Biotechnology, Genomics & Precision Medicine
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Digitalization, Cloud, Big Data & Cybersecurity
• 4.2. Major Trends
  • 4.2.1 Growth In Monoclonal Antibody-Based Canine Cancer Treatments
  • 4.2.2 Rising Use Of Mabs For Autoimmune Disorders In Dogs
  • 4.2.3 Expansion Of Veterinary Dermatology Applications
  • 4.2.4 Increasing Adoption Of Targeted Pain Management Therapies
  • 4.2.5 Development Of Species-Specific Antibody Therapies For Cats, Horses, And Livestock

5. Monoclonal Antibodies In Veterinary Health Market Analysis Of End Use Industries

• 5.1 Veterinary Hospitals
• 5.2 Pet Clinics
• 5.3 Research Institutions
• 5.4 Animal Care Centers
• 5.5 Specialty Veterinary Centers

6. Monoclonal Antibodies In Veterinary Health Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Monoclonal Antibodies In Veterinary Health Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Monoclonal Antibodies In Veterinary Health PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Monoclonal Antibodies In Veterinary Health Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Monoclonal Antibodies In Veterinary Health Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Monoclonal Antibodies In Veterinary Health Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Monoclonal Antibodies In Veterinary Health Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Monoclonal Antibodies In Veterinary Health Market Segmentation

• 9.1. Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Monoclonal Antibodies (mAbs), Glucocorticoids, Antihistamines, Immunosuppressants, Other Products
• 9.2. Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Dogs, Cats, Horses, Livestock, Other Animals
• 9.3. Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Allergic Skin Disease, Autoimmune Disorders, Infectious Diseases, Cancer Or Tumor Therapy, Other Indications
• 9.4. Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Injectable, Oral, Topical
• 9.5. Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Veterinary Clinics, Specialized Animal Hospitals, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
• 9.6. Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Lokivetmab, Felvetmab, Investigational Monoclonal Antibodies, Equine-specific mAbs
• 9.7. Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Glucocorticoids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Prednisone, Prednisolone, Dexamethasone, Methylprednisolone, Hydrocortisone, Triamcinolone
• 9.8. Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Diphenhydramine, Hydroxyzine, Cetirizine, Loratadine, Chlorpheniramine
• 9.9. Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Immunosuppressants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cyclosporine, Tacrolimus, Azathioprine, Mycophenolate Mofetil
• 9.10. Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Essential Fatty Acid Supplements, Medicated Shampoos And Sprays, Allergen-Specific Immunotherapy (ASIT), Skin Barrier Repair Creams, Nutraceuticals And Probiotics

10. Monoclonal Antibodies In Veterinary Health Market Regional And Country Analysis

• 10.1. Global Monoclonal Antibodies In Veterinary Health Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Monoclonal Antibodies In Veterinary Health Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market

• 11.1. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Monoclonal Antibodies In Veterinary Health Market

• 12.1. China Monoclonal Antibodies In Veterinary Health Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Monoclonal Antibodies In Veterinary Health Market

• 13.1. India Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Monoclonal Antibodies In Veterinary Health Market

• 14.1. Japan Monoclonal Antibodies In Veterinary Health Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Monoclonal Antibodies In Veterinary Health Market

• 15.1. Australia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Monoclonal Antibodies In Veterinary Health Market

• 16.1. Indonesia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Monoclonal Antibodies In Veterinary Health Market

• 17.1. South Korea Monoclonal Antibodies In Veterinary Health Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Monoclonal Antibodies In Veterinary Health Market

• 18.1. Taiwan Monoclonal Antibodies In Veterinary Health Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Monoclonal Antibodies In Veterinary Health Market

• 19.1. South East Asia Monoclonal Antibodies In Veterinary Health Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Monoclonal Antibodies In Veterinary Health Market

• 20.1. Western Europe Monoclonal Antibodies In Veterinary Health Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Monoclonal Antibodies In Veterinary Health Market

• 21.1. UK Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Monoclonal Antibodies In Veterinary Health Market

• 22.1. Germany Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Monoclonal Antibodies In Veterinary Health Market

• 23.1. France Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Monoclonal Antibodies In Veterinary Health Market

• 24.1. Italy Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Monoclonal Antibodies In Veterinary Health Market

• 25.1. Spain Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Monoclonal Antibodies In Veterinary Health Market

• 26.1. Eastern Europe Monoclonal Antibodies In Veterinary Health Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Monoclonal Antibodies In Veterinary Health Market

• 27.1. Russia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Monoclonal Antibodies In Veterinary Health Market

• 28.1. North America Monoclonal Antibodies In Veterinary Health Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Monoclonal Antibodies In Veterinary Health Market

• 29.1. USA Monoclonal Antibodies In Veterinary Health Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Monoclonal Antibodies In Veterinary Health Market

• 30.1. Canada Monoclonal Antibodies In Veterinary Health Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Monoclonal Antibodies In Veterinary Health Market

• 31.1. South America Monoclonal Antibodies In Veterinary Health Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Monoclonal Antibodies In Veterinary Health Market

• 32.1. Brazil Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Monoclonal Antibodies In Veterinary Health Market

• 33.1. Middle East Monoclonal Antibodies In Veterinary Health Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Monoclonal Antibodies In Veterinary Health Market

• 34.1. Africa Monoclonal Antibodies In Veterinary Health Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Monoclonal Antibodies In Veterinary Health Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Monoclonal Antibodies In Veterinary Health Market Regulatory and Investment Landscape

36. Monoclonal Antibodies In Veterinary Health Market Competitive Landscape And Company Profiles

• 36.1. Monoclonal Antibodies In Veterinary Health Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Monoclonal Antibodies In Veterinary Health Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Monoclonal Antibodies In Veterinary Health Market Company Profiles
  • 36.3.1. Zoetis Inc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. MSD Animal Health Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Heska Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Monoclonal Antibodies In Veterinary Health Market Other Major And Innovative Companies

• Ceva Sante Animale S.A., Biogenesis Bago S.A., PetMedix Ltd, Merck & Co Inc, Virbac SA, Kindred Biosciences Inc, Dechra Pharmaceuticals, Vetigenics, Akston Biosciences Corporation, MabGenesis Inc, IDEXX Laboratories Inc, Nexvet Biopharma, Epitopix LLC, Indian Immunologicals Ltd, Vetoquinol

38. Global Monoclonal Antibodies In Veterinary Health Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Monoclonal Antibodies In Veterinary Health Market

40. Monoclonal Antibodies In Veterinary Health Market High Potential Countries, Segments and Strategies

• 40.1 Monoclonal Antibodies In Veterinary Health Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Monoclonal Antibodies In Veterinary Health Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Monoclonal Antibodies In Veterinary Health Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer